Stemgent® Reprogramming Lentivirus: Human c-Myc
The Stemgent® Reprogramming Lentivirus: Human c-Myc provides an affordable method for generating iPS cells. The hc-Myc lentivirus, along with the hOct4, hKlf4, and hSox2 prepackaged lentivirus, is tested and proven to reprogram human fibroblast cells1.
1. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
Stemgent® Reprogramming Lentivirus: Human c-Myc
The expression of the four human transcription factors (TFs) (Oct4, Klf4, Sox2, and c-Myc) has been shown to reprogram human adult fibroblasts to an embryonic stem (ES) cell-like state known as the induced pluripotent stem (iPS) cell1. The Stemgent® Lentivirus Reprogramming Set : Human OKSM consists of four lentiviruses, each of which is capable of expressing one of these four factors when transduced into mammalian cells. Each unique virus is provided as a VSV-G pseudotyped virus stock capable of efficiently transducing a wide range cell types.
References
- Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
For research use only. Not for use in diagnostic procedures. Not for resale.
Stemgent® Reprogramming Lentivirus: Human c-Myc
| Size / Quantity | ST070014-1ML |
| Sterility | Tested to be free of bacteria. TSB (tryptic soy broth) was inoculated with the virus and cultured for 4 days at 30°C and 3 days at room temperature to assay for bacterial growth. |
| Storage and Stability | Store at -70°C for up to 9 months. Keep frozen until use. Avoid freeze thaw cycles. |
| Quality Control | Viral concentration determined by p24 (capsid antigen) ELISA assay. Transcription factor protein expression verified by immunocytochemistry analysis of transduced mammalian cells. |
| Safety Precautions | The greatest safety risk associated with viral delivery systems stems from the potential generation of recombinant viruses that are capable of autonomous replication during the packaging process. The Stemgent® Reprogramming Lentivirus platform eliminates these hazards by combining a disabled viral genome with a unique manufacturing process. Also, gene functions that facilitate the enclosing of the silencing sequence in a viral capsid (e.g., Gag, Pol, Env) are distributed into multiple helper plasmids (which do not contain significant regions of homology) during packaging. This tactic further minimizes the probability of recombination events that might otherwise generate viruses capable of autonomous replication. With these safety measures in place, the Stemgent® Reprogramming Lentivirus particles can be employed in standard Biosafety Level 2 tissue culture facilities and should be treated with the same level of caution as with any other potentially infectious agent. Also, please note that the c-Myc and Klf4 proteins are reported to demonstrate oncogenic properties. |
| References |
|
| Restricted Use | For restrictions related to the use of this product please refer to the accompanying Restricted Use License. |
| Notice to Purchaser | Purchaser represents and warrants that it will use the Stemgent® Reprogramming Lentivirus: Human c-Myc purely for research purposes, not for diagnostic use, not for resale, and not for use in humans or veterinary applications. Stemgent will not be held responsible for patent infringement or other violations that may occur with the use of our products. |
| Sigma Product Statement | Stemgent® Reprogramming Lentivirus products are sold through Sigma-Aldrich Inc. Sigma-Aldrich Inc. warrants that its products conform to the information contained in this and in other Sigma-Aldrich publications. Purchaser must determine the suitability of the product(s) for their particular use. Additional terms and conditions may apply. Please see the reverse side of the invoice or packing slip. |
Have you published research involving the use of our products? If so, we'd love to hear about it. Please let us know!





